Canadian cannabis sales November 2025: A snapshot
Canadian cannabis sales November 2025 showed renewed momentum as national retail receipts rose to C$477.9 million in November. This uptick sets the stage for a focused look at sales trends and market insights. It also points to shifting consumer behavior in late 2025. Because regulators and retailers adjusted pricing and store counts, shoppers returned to legal channels more often.
In this analysis we break down monthly and year over year changes. We compare provincial patterns such as Ontario and Alberta against British Columbia and Quebec. Meanwhile we examine drivers behind the 10.2 percent per day increase and the impact of falling flower prices.
Readers will get clear numbers, expert context, and implications for investors and operators. Therefore expect charts, provincial snapshots, and evidence about illicit market migration. As a result you will understand whether growth is temporary or sustainable. Finally we highlight what to watch in December data due on February 20. We explain what that means for 2025 full year trends.
Canadian cannabis sales November 2025: Market trends analysis
November 2025 marked a clear uptick in legal retail receipts, with Canadian cannabis sales November 2025 reaching C$477.9 million. Sales rose 6.6 percent from October, and they were up 4.6 percent year over year. However, the month had fewer days, so per-day sales rose 10.2 percent. Regional patterns varied sharply, driven by store counts and price shifts.
Key trends and data points
- National volume: C$477.9 million in November, a 6.6 percent monthly gain.
- Per-day strength: 10.2 percent increase because November had fewer days.
- Ontario: sales down 5.2 percent from October and down 3 percent year over year.
- Alberta: down 5.5 percent from October but up 2 percent year over year.
- British Columbia: rebounded 250 percent sequentially and rose 9 percent year over year.
- Quebec: down 4.1 percent from October yet up 31 percent year over year.
- Drivers: more stores and falling flower prices drew customers from the illicit market.
- Therefore outlook: modest growth, with 2025 up about 4.2 percent year to date.
Full data are available from Statistics Canada.
Alan Brochstein’s analysis and context appear on New Cannabis Ventures.
For related market coverage see My CBD Advisor.
Image source: Canadian cannabis market growth image
Sales drivers and challenges: What moved Canadian cannabis sales in November 2025
Retail growth in November came from a mix of supply, price, and access factors. Because retailers expanded storefront counts, more consumers found legal options closer to home. Meanwhile falling flower prices increased basket sizes, and that drew buyers away from the illicit market.
Main drivers
- Store expansion: More licensed stores improved legal accessibility across provinces, boosting legal channel share. For example, increased retail density in smaller markets led to steady traffic.
- Lower flower prices: Reduced wholesale and retail flower prices raised unit sales, because consumers respond strongly to value on core products.
- Illicit market migration: As legal prices fell and selection widened, consumers shifted to licensed sellers, increasing reported legal sales.
- Regional rebounds: British Columbia saw a strong sequential recovery, which lifted national totals.
Primary challenges
- Price pressure: Lower prices squeeze margins, and therefore many producers face profitability stress. Retailers must balance promotions with margin preservation.
- Supply chain volatility: Seasonal shortages and logistics delays created uneven product availability, which hurt some store sales volumes.
- Regulatory friction: Differing provincial rules and licensing timelines complicate expansion plans, and they raise compliance costs for operators.
- Provincial heterogeneity: Ontario and Alberta lagged month over month, which shows risks from uneven demand.
For official data and further context see Statistics Canada: Statistics Canada and industry analysis from New Cannabis Ventures: New Cannabis Ventures.
Product type sales breakdown — November 2025
Below is an estimated breakdown of Canadian cannabis sales by product type for November 2025. The table allocates the national total of C$477.9 million across major categories. These estimates reflect market mix trends and the impact of lower flower prices.
| Product type | Estimated sales (C$ million) | Market share (%) |
|---|---|---|
| Dried flower | C$229.4 | 48 |
| Oils and extracts | C$95.6 | 20 |
| Edibles | C$71.7 | 15 |
| Vapes | C$57.3 | 12 |
| Other products (topicals, seeds, accessories) | C$23.9 | 5 |
Key takeaways
- Dried flower remained the largest category, but volumes grew because prices fell.
- Oils and extracts held strong share as consumers sought potency and convenience.
- Therefore edibles and vapes gained modest traction, driven by product innovation and promotions.
Note: Figures are approximate allocations of the C$477.9 million national total for November 2025. They are intended to illustrate product mix and market shares rather than serve as official Statistics Canada breakdowns.
Conclusion
Canadian cannabis sales November 2025 delivered a clear, if measured, rebound. National retail receipts climbed to C$477.9 million. Sales rose 6.6 percent from October and 4.6 percent year over year. However, per-day sales jumped 10.2 percent because November had fewer days.
Regional performance varied sharply. British Columbia staged a strong sequential recovery while Ontario and Alberta lagged. Meanwhile Quebec showed large year-over-year gains despite a monthly dip. Key drivers included expanded store counts and falling flower prices, which pulled customers from the illicit market. At the same time margins tightened for many producers due to price pressure. Supply chain volatility and varied provincial regulations remain core challenges for retailers.
Therefore stakeholders should treat November as cautious progress rather than a structural turning point. December data due on February 20 will clarify momentum into year end. As a result, expect continued modest growth with intermittent volatility.
MyCBDAdvisor remains dedicated to full-spectrum, research-driven coverage of CBD and cannabinoids. Visit MyCBDAdvisor for detailed guides, data, and market analysis you can trust. Note about EMP0: EMP0 appears as an internal reference in our dataset and should be reviewed alongside official releases.
Frequently Asked Questions (FAQs)
Why did Canadian cannabis sales rise in November 2025?
Sales rose to C$477.9 million because more licensed stores opened and flower prices fell. Therefore legal options became more attractive than illicit channels. Meanwhile promotions and wider selection supported higher basket sizes.
Which product types led sales in November 2025?
Dried flower remained the top seller, followed by oils and extracts. Edibles and vapes gained share due to innovation and targeted marketing. As a result flower still dominated but the market diversified.
Did all provinces show the same trends?
No. British Columbia rebounded strongly, while Ontario and Alberta fell month over month. Quebec grew year over year despite a monthly dip. Thus provincial rules and store density drove divergence.
What main challenges could slow future growth?
Price pressure and squeezed margins pose a major risk. Also supply chain volatility and varying provincial regulations hinder consistent expansion. Therefore operators must manage costs carefully.
What should consumers and industry watch next?
Watch December data due on February 20 and follow store openings and price trends. If legal prices stay competitive, expect steady migration from the illicit market. Overall the outlook is cautiously optimistic.
